$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Oct 23, 2025)
$6.05B
Market Cap
-
P/E Ratio
-5.4
EPS
$78.48
52 Week High
$30.04
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Crispr Therapeutics AG (CRSP) is a pioneering gene editing company leveraging its proprietary CRISPR/Cas9 technology to develop breakthrough therapies for serious genetic disorders, such as sickle cell disease and beta-thalassemia. Based in Zug, Switzerland, the company is actively expanding its clinical pipeline and forging strategic collaborations to translate its innovative science into effective treatments. With a robust portfolio and a commitment to improving patient outcomes, Crispr Therapeutics is positioned as a leader in the evolving biopharmaceutical industry, aiming to redefine the landscape of medicine through advanced gene editing solutions.